Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.cnbc.com/2025/08/07/eli-lilly-lly-q2-2025-earnings-report.html
0
0
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar - CNBC
+ 76 more
8/7/25 at 10:54am
Organization
CNBC
Author
Annika Kim Constantino
39 words
0
Comments
Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs.
Business & Industrial
Eli Lilly
tirzepatide
CNBC
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...